017 | Targeting lipogenesis promotes the synergistic effect of the selective HDAC inhibitor ITF3756 with bortezomib in colon cancer cells: Marzia Franzò1, Giovanni Pratelli1, Federica Affranchi2, Antonietta Notaro2, Michela Giuliano2, Sonia Emanuele1 | 1Department of Biomedicine, Neuroscience and Advanced Diagnostics, Biochemistry Building, University of Palermo, Italy; 2Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Italy. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, [S. l.], v. 99, n. s1, 2026. DOI: 10.4081/jbr.2026.15269. Disponível em: https://www.pagepressjournals.org/jbr/article/view/15269. Acesso em: 7 may. 2026.